| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Investigative Ophthalmology & Visual Science, Vol 37, 2002-2014, Copyright © 1996 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
I Selles-Navarro, MP Villegas-Perez, M Salvador-Silva, JM Ruiz-Gomez and M Vidal- Sanz
Laboratorio de Oftalmologia Experimental, Facultad de Medicina, Universidad de Murcia, Madrid, Spain.
PURPOSE: To quantitate in vivo retinal ganglion cell (RGC) survival after transient periods of pressure-induced ischemia of the rat retina and after different survival intervals. METHODS: In adult rats, RGCs were labeled with fluorogold applied to their main targets in the brain. Seven days later, in several groups of rats, the left retinas were subjected to transient periods of ischemia of 30, 45, 60, 75, 90, 105, or 120 minutes, respectively, by increasing the intraocular pressure (IOP) of the left eye above systolic values. Five, 7, 14, and 30 days later, the rats were killed, and their retinas were prepared as wholemounts for examination under fluorescence microscopy to estimate RGC survival. RESULTS: The authors found that periods of ischemia of 30 and 45 minutes do not induce RGC death; longer periods of transient ischemia induce the death of a proportion of RGCs, and the proportion increases with the duration of the ischemia; RGC death, which can be observed as early as 5 days after ischemia, continues during the 30-day study period; and periods of ischemia that last 90 minutes or more cause the death of approximately 95% of the RGC population 30 days later. CONCLUSIONS: Increases of the IOP above systolic levels for periods of 60 minutes or more result in RGC loss in the rat retina. Both the duration of the initial transient period of ischemia and the duration of the survival period influence the proportion of RGC death.
This article has been cited by other articles:
|
|
 |
|
  T. Jehle, K. Wingert, C. Dimitriu, W. Meschede, J. Lasseck, M. Bach, and W. A. Lagreze Quantification of Ischemic Damage in the Rat Retina: A Comparative Study Using Evoked Potentials, Electroretinography, and Histology Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1056 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Chauhan, T. L. LeVatte, K. L. Garnier, F. Tremblay, I.-H. Pang, A. F. Clark, and M. L. Archibald Semiquantitative Optic Nerve Grading Scheme for Determining Axonal Loss in Experimental Optic Neuropathy Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 634 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Hains and S. G. Waxman Neuroprotection by Sodium Channel Blockade with Phenytoin in an Experimental Model of Glaucoma Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4164 - 4169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mayor-Torroglosa, P. De la Villa, M. E. Rodriguez, M. P. L. Lopez-Herrera, M. Aviles-Trigueros, A. Garcia-Aviles, J. Miralles de Imperial, M. P. Villegas-Perez, and M. Vidal-Sanz Ischemia Results 3 Months Later in Altered ERG, Degeneration of Inner Layers, and Deafferented Tectum: Neuroprotection with Brimonidine Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3825 - 3835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Mali, M. Cheng, and S. K. Chintala Plasminogen activators promote excitotoxicity-induced retinal damage FASEB J, August 1, 2005; 19(10): 1280 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Chauhan, T. L. LeVatte, C. A. Jollimore, P. K. Yu, H. A. Reitsamer, M. E. M. Kelly, D.-Y. Yu, F. Tremblay, and M. L. Archibald Model of Endothelin-1-Induced Chronic Optic Neuropathy in Rat Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 144 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Sanchez, C. K. Chan, S. Garg, J. M. K. Kwong, M. J. Wong, A. A. Sadun, and T. T. Lam Interleukin-6 in Retinal Ischemia Reperfusion Injury in Rats Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 4006 - 4011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Guo, P. Saloupis, S. J. Shaw, and D. W. Rickman Engraftment of Adult Neural Progenitor Cells Transplanted to Rat Retina Injured by Transient Ischemia Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3194 - 3201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Grozdanic, D. S. Sakaguchi, Y. H. Kwon, R. H. Kardon, and I. M. Sonea Functional Characterization of Retina and Optic Nerve after Acute Ocular Ischemia in Rats Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2597 - 2605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Garcia, V. Forster, D. Hicks, and E. Vecino Effects of Muller Glia on Cell Survival and Neuritogenesis in Adult Porcine Retina In Vitro Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3735 - 3743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Chintala, X. Zhang, J. S. Austin, and M. E. Fini Deficiency in Matrix Metalloproteinase Gelatinase B (MMP-9) Protects against Retinal Ganglion Cell Death after Optic Nerve Ligation J. Biol. Chem., November 27, 2002; 277(49): 47461 - 47468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kashiwagi, Y. Iizuka, M. Araie, Y. Suzuki, and S. Tsukahara Effects of Retinal Glial Cells on Isolated Rat Retinal Ganglion Cells Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2686 - 2694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Lafuente, M. P. Villegas-Perez, P. Sobrado-Calvo, A. Garcia-Aviles, J. Miralles de Imperial, and M. Vidal-Sanz Neuroprotective Effects of {alpha}2-Selective Adrenergic Agonists against Ischemia-Induced Retinal Ganglion Cell Death Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2074 - 2084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Park, F. Cozier, O. C. Ong, and J. Caprioli Induction of Heat Shock Protein 72 Protects Retinal Ganglion Cells in a Rat Glaucoma Model Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1522 - 1530. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Tezel and M. B. Wax Increased Production of Tumor Necrosis Factor-alpha by Glial Cells Exposed to Simulated Ischemia or Elevated Hydrostatic Pressure Induces Apoptosis in Cocultured Retinal Ganglion Cells J. Neurosci., December 1, 2000; 20(23): 8693 - 8700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Mittag, J. Danias, G. Pohorenec, H.-M. Yuan, E. Burakgazi, R. Chalmers–Redman, S. M. Podos, and W. G. Tatton Retinal Damage after 3 to 4 Months of Elevated Intraocular Pressure in a Rat Glaucoma Model Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3451 - 3459. [Abstract] [Full Text]
|
|
|
|
|
|
E. C. Johnson, L. M. H. Deppmeier, S. K. F. Wentzien, I. Hsu, and J. C. Morrison Chronology of Optic Nerve Head and Retinal Responses to Elevated Intraocular Pressure Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 431 - 442. [Abstract] [Full Text]
|
|
|
|
|
|
M. Lehmann, A. Fournier, I. Selles-Navarro, P. Dergham, A. Sebok, N. Leclerc, G. Tigyi, and L. McKerracher Inactivation of Rho Signaling Pathway Promotes CNS Axon Regeneration J. Neurosci., September 1, 1999; 19(17): 7537 - 7547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Neufeld, A. Sawada, and B. Becker Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma PNAS, August 17, 1999; 96(17): 9944 - 9948. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
